Skip to main content
. 2022 Jan 24;12:788706. doi: 10.3389/fendo.2021.788706

Table 1.

Characteristics of patients undergoing fresh cycles with embryo transfer.

Mean (SD) or Median (Q1-Q3) N (%)
Female age(year) 31.16 (4.39)
Female age group(year)
 <35 32,816 (77.89%)
 >=35, <40 7,694 (18.26%)
 >=40 1,622 (3.85%)
BMI (kg/m2) 22.34 (3.12)
BMI group(kg/m2)
 <18.5 3,315 (7.91%)
 >=18.5, <24.9 30,712 (73.28%)
 >=24.9, <30 7,064 (16.86%)
 >=30 819 (1.95%)
Infertility type
 Primary Infertility 22,505 (54.37%)
 Secondary Infertility 18,887 (45.63%)
Basal AMH(ng/ml) 3.13 (1.92-4.98)
Basal FSH(mIU/ml) 7.30 (1.99)
Basal E2(pg/ml) 45.88 (25.79)
Duration of infertility(year) 3.00 (2.00-5.00)
AFC 11.71 (4.92)
COS protocols
GnRH agonist protocol 34,388 (81.62%)
GnRH antagonist protocol 7,744 (18.38%)
Gn dosage(IU) 2389.14 (892.99)
Gn duration(day) 10.36 (2.18)
E2 level on hCG trigger day(pg/ml) 2263.00 (1348.89-3571.75)
LH level on hCG trigger day(mIU/ml) 1.73 (1.05-2.70)
P level on hCG trigger day(ng/ml) 0.94 (0.65-1.35)
EMT on hCG trigger day (mm) 11.61 (2.45)
No. of retrieved oocytes 9.75 (4.53)
No. of embryo transfer 1.61(0.49)
Embryo type
 Embryos in cleavage stage 33,476 (79.48%)
 Blastocyst 8,459 (20.08%)
 others 182 (0.43%)
Embryo quality
 good 30,039 (71.62%)
 Not good 11,886 (28.34%)
 others 19 (0.05%)
Miscarriage rate(%) 3039 (12.64%)
Live birth rate(%) 18,243 (43.30%)
Clinical pregnancy rate(%) 24,048 (57.08%)

BMI, body mass index; AMH, anti-Mullerian hormone; AFC, antral follicle counting; controlled COS, ovarian stimulation; GnR,H gonadotropin-releasing hormone; Gn, gonadotropin; E2, estradiol; LH, luteinizing hormone; P, progesterone; EMT, endometrium thickness.